Aims This study aimed to clarify trends in clinical performance in diabetic patients over a 12-year period in primary care clinics and hospitals in Japan. Materials and methods The Shiga Diabetes Clinical Survey records medical performance in diabetic patients in primary care clinics and hospitals in Shiga Prefecture, Japan. In this study, laboratory data, modality of treatment for diabetes, and status of examination for diabetic complications were examined using results of surveys in 2000, 2006, and 2012. The study included 17,870, 18,398, and 24,219 patients for those years, respectively. Results Mean glycated hemoglobin (HbA1 c ) level significantly improved over 12 years and was significantly lower in the primary care clinics group than the hospitals group (7.3 ± 1.5 vs. 7.4 ± 1.4 % in 2000, 7.2 ± 1.2 vs. 7.4 ± 1.3 % in 2006, and 6.9 ± 1.0 vs. 7.1 ± 1.1 % in 2012). With regard to diabetic treatment modality, patients treated in hospitals used insulin more frequently than those in primary care clinics. The proportion of patients examined for diabetic complications increased but did not reach 50 % in 2012. Mean blood pressure and low-density lipoprotein cholesterol levels were lowered, but blood pressure control was worse than that of low-density lipoprotein cholesterol. Conclusions This study shows that glycemic control in both primary care clinics and hospitals has improved and was almost acceptable. However, examinations for diabetic complications and the control of blood pressure were still insufficient.
Introduction
The number of diabetic patients has been increasing in Asia, including in Japan. The International Diabetes Federation reports that four Asian countries (China, India, Indonesia, and Japan) were ranked in the top ten countries/ territories in the world for number of diabetic patients [1] . It is presumed that 7.2 million adults in Japan are diabetic, and the diabetic population of Southeast Asia has been expanding rapidly and has reached almost one fifth of all cases worldwide [1] . Diabetes leads to serious problems in various parts of the body and is a leading cause of death when appropriate treatment is not received. In recent years, new drugs have been developed for treating diabetes, but there is a question of whether glycemic control has improved. It is important to clarify the current status of diabetic medical performance and its trends to improve glycemic control.
In this study, we analyzed three cross-sectional data collections from the Shiga Diabetes Clinical Survey performed in 2000, 2006, and 2012 . This survey was targeted to all primary care clinics (PCCs) and hospitals in Shiga prefecture. We compared 12-year trends between PCCs and hospitals regarding glycemic control, diabetic treatment, examination of diabetic complications, and control of blood pressure and low-density lipoprotein (LDL) cholesterol. In this study, most PCCs were run by general practitioners (GPs) and most hospitals by diabetologists. There are very few reports comparing diabetes management, including glycemic control and diabetic treatment, between PCCs and hospitals or GPs and diabetologists in Japan [2] .
As Shiga prefecture falls around the mean of all prefectures in Japan with respect to economic activity, such as gross regional product and population, results of this study may be a sufficient representation of medical data of diabetic patients in all of Japan [3] . Thus, results of this study suggest the actual medical performance of diabetic patients treated by GPs or diabetologists throughout Japan.
Materials and methods

Shiga Diabetes Clinical Survey
Shiga prefecture is located in the central part of Japan. We researched weight, height, blood pressure, the most recent data for glycated hemoglobin A1 c (HbA1 c ), other laboratory data, drug therapy, and information on retinal screening and examination of microalbuminuria within 1 year. Each PCC and hospital collected these data in a registration form, and these were collected through each regional medical association. In this study, we analyzed patients aged C20 years for a total of 17,870 patients in 2000, 18,398 in 2006, and 24,219 in 2012. The majority of blood examination data were not fasting; fasting data were 31.7 % in 2000, 20.6 % in 2006, and 14.2 % in 2012. The value for HbA1 c , which was measured using the methods of the Japan Diabetes Society (JDS), is estimated as the National Glycohemoglobin Standardization Program (NGSP)-equivalent value by the following formula: HbA1 c (NGSP) (%) = 1.02 9 HbA1 c (JDS) (%) ? 0.25 [5] . Hypertension was defined as blood pressure C140/ 90 mmHg [6] or taking antihypertensive medications.
Statistical analysis
Patients' characteristics and differences between patients treated in PCCs and those treated in hospitals for each survey year were compared using t tests for continuous variables and the chi-square test for categorical variables. A regression analysis was used to examine the trend in HbA1 c values. A logistic analysis was used to examine the trend in change of diabetic treatment modality and prevalence of hypertension. P values \0.05 were considered to be statistically significant. All analyses were carried out using IBM SPSS Statistics version 22 for Windows (IBM Corp., USA).
Results
Characteristics
Clinical characteristics of each study population are shown in Table 1 
HbA1 c values
Mean HbA1 c levels significantly improved over 12 years (mean ± standard deviation (SD) 7.3 ± 1.4 % in 2000; 7.3 ± 1.3 % in 2006; 7.1 ± 1.1 % in 2012; P for trend \0.001); mean HbA1 c levels for patients treated in PCCs were significantly lower than for those treated in hospitals (Table 1) . The proportion of patients with HbA1 c levels \7.0 %, which was a target level to prevent diabetic microangiopathy [7] , was 48. (Fig. 1) .
Diabetic treatment modality
The proportion of all patients on diet and exercise only (no medication), which was 24. Glucagon-like peptide-1 (GLP-1) receptor agonists as a new treatment were added in 2012. These trends were confirmed in both PCCs and hospitals (Fig. 2 ). There were a few differences between PCCs and hospitals: patients treated in PCCs used more OHA and less insulin than patients in hospitals.
Glycemic control by diabetic treatment
Mean HbA1 c levels in the diet and exercise only group were the lowest of all treatment groups and did not change over 12 years (6.4 ± 1.0 % in 2000, 6.5 ± 0.9 % in 2006, and 6.4 ± 0.8 % in 2012). The rank order of mean HbA1 c levels starting with the lowest by diabetic treatment modality were diet and exercise only, OHA, insulin, and OHA plus insulin therapy (Fig. 3) . Trends in glycemic control were almost the same in the OHA group, insulin group, and OHA with insulin group. Mean HbA1 c levels of each group improved in 2012 both in PCCs and hospitals (P for trend \0.001). (Fig. 3) .
Examination of microalbuminuria and retinal screening
Quantitative measurement of urinary albumin of patients within 1 year increased over the 12 years (20.7 % in 2000, 27.4 % in 2006, and 37.2 % in 2012, P for trend \0.001). The proportion of patients who took urinary albumin measurement in hospitals were higher than that in PCCs (Fig. 4a ). With stratification by HbA1c level, as glycemic control worsened, it tended to increase the proportion of patients with urinary albumin measurement in both groups (Fig. 4b) .
The number of patients who received retinal screening within 1 year increased slightly (44.8 % in 2000, 46.5 % in 2006, and 49.1 % in 2012, P for trend \0.001), with patients treated in hospitals receiving retinal screening more frequently than those in PCCs (Fig. 5a ). With stratification by HbA1 c , as glycemic control worsened, the proportion of patients screened tended to be higher both groups. In PCCs, the rate screening rose slightly in 2012 compared with 2000, whereas there was no increase in hospitals over time except for the category of HbA1 c \ 6 % (Fig. 5b) . 
Control of blood pressure and LDL-cholesterol
The prevalence of hypertension significantly increased, from 66.7 % in 2000, to 66.4 % in 2006, and to 69.1 % in 2012, P for trend \0.001. Mean blood pressure improved over the 12 years both in PCCs and hospitals (Table 1) , and the proportion of patients who met the Japan Diabetes Society guidelines of 130/80 mmHg [8] increased (Table 2) . However, the control rate remained low (24. Total cholesterol, LDL-cholesterol, and non-high-density lipoprotein (HDL)-cholesterol levels improved over the 12 years, although triglyceride and HDL-cholesterol levels did not change (Table 1) . Control of LDL-cholesterol levels has also improved, with patients treated in hospitals being controlled better than those in PCCs (Table 2) . Most patients on lipid-lowering drugs achieved the treatment goal of LDL-cholesterol \120 mg/dl recommended by the Japan Atherosclerosis Society (Table 2) . [9] . Our results corresponded with these findings, although JDDM was a study of diabetologists only. Several probable reasons exist for the recent improvement of glycemic control in Japan. One is that the number of patients treated for diabetes has increased. According to the National Health and Nutrition Survey in Japan, the proportion of patients who have never been treated has been decreasing, and the proportion of probable diabetic patients treated continuously has been increasing-up to 65.2 % in the latest data-with a 20 % increase from 15 years previously [10] . These findings suggest the need to publicize treatment for diabetes, which might contribute to improvements in glycemic control. Also, it is possible that advances in diabetes treatment played a role, as new diabetic drugs have been developed in recent years. However, there also may be a possibility that the number of mild diabetic patients has increased due to increased public awareness of diabetes in Japan.
Regarding differences between PCCs and hospitals, over the 12 years, mean HbA1 c levels for patients treated in PCCs were significantly lower than for those treated in hospitals. A large cross-sectional survey in Japan showed similar results [11] . In other countries, patients treated by GPs also had lower HbA1 c levels than those treated by diabetologists [12] [13] [14] . In Italy, glycemic control between GPs and diabetologists did not differ [15] , but when the same population was limited to HbA1 c [ 8 %, patients in the GP group had better control than those in the diabetologists group [16] . The review that summarized these studies indicated that the magnitude of difference between GP and specialist care is inconsequential [17] . Most studies were cross-sectional; our study was also based on crosssectional data, but interestingly, our study showed that the same trend was observed over the 12-year period. In Japan, patients who do not achieve glycemic targets with treatment in PCCs are referred to hospitals. When they are treated and glycemic control improves in hospitals, they come back to their original PCC. This cooperation between PCCs and hospitals might be one reason why the mean HbA1 c levels of patients treated in hospitals was difficult to improve. It is not enough to provide sufficient treatment for all diabetic patients using diabetologists alone. Closer cooperation between PCCs and hospitals is needed to implement better quality care for diabetic patients.
In terms of trends in diabetic treatment modalities, JDDM reported that the proportion of patients on diet and exercise only has decreased and the use of OHA (the most commonly used treatment) has slightly increased; furthermore, the use of insulin only has decreased and OHA and insulin together has increased [9] . This pattern of treatment modalities resembles our results. According to data from the US Centers for Disease Control and Prevention [18, 19] , trends are almost the same as those in the current study, although the proportions of patients treated with OHA and both OHA and insulin were higher in the US study than in ours. It is noteworthy that the proportion of patients treated with a combination therapy of OHA and insulin increased substantially by approximately three fold over our 12-year study. We have no information about kinds of OHA and insulin in this study; however, we presume two reasons for the increase. The first is that basal long-acting insulin analogs became available in 2001. It has been reported that basal-supported orally administered therapy is popular, and many patients receive the combination of insulin analogs and OHA in Japan [11] . In a consensus statement for the medical management of type 2 diabetes, basal insulin is one of the recommended choices as a second-line agent added to metformin [20] . The second reason is that new medicines in the form of incretinrelated drugs have been available since 2009. In particular, the glucose-lowering efficacy of dipeptidyl peptidase-4 (DPP-4) inhibitors is greater in Asian patients than in Caucasian patients [21] . In Japan, the use of DPP-4 inhibitors has remarkably increased both for monotherapy and combination therapy [9] . As first-line treatment, DPP-4 inhibitors might begin being used earlier than before, and so the proportion of patients treated with diet and exercise only might decline. These changes due to DPP-4 inhibitors are likely to be one of the reasons for the improvement of glycemic control.
The proportion of the patients treated with insulin or combination therapy with OHA and insulin was higher in the hospitals group than the PCCs group. Other studies have also shown that insulin is used more often by diabetologists than by GPs [2, 12, 22] . The reason suggested is that diabetologists treat patients with more severe diabetes and prescribe more insulin than GPs. The trend in glycemic control by treatment was almost the same in PCCs and hospitals, although mean HbA1 c levels were sustained between 2000 and 2006 in hospitals. Mean HbA1 c levels were higher in increasing order of diet and exercise only, OHA, insulin, and OHA with insulin. This trend agrees with that in a previous report [23] .
Patients in whom microalbuminuria was assessed increased but remained at \40 %. The proportion of patients who received microalbuminuria assessment was higher in hospitals than in PCCs and increased over time. Half of all patients had retinal screening, but the rate rose only 5 % between 2012 and 2000; the proportion of patients in hospitals was higher than that in PCCs over time. In reports from other countries, findings are not consistent concerning whether the examination rate of microalbuminuria and retinal screening is higher in PCCs or hospitals [13, 15] because every country has a different system of hospital and PCC cooperation. In reports from Japan, both screenings were more frequently performed by diabetologists than by GPs [24] [25] [26] . Many diabetologists belong to hospitals, and the ophthalmology department is established in the same hospital as the internal medicine department in Japan. It is therefore easy for patients treated in the hospital or by diabetologists to undergo retinal screening.
Two kinds of notebooks for the cooperation of physicians and ophthalmologists were issued by the Japanese Society of Ophthalmic Diabetology (JSOD) in 2002 and by the Japan Association for Diabetes Education and Care in 2010. As a result, physicians and patients have been recognizing the necessity of retinal screening. The JSOD reported that utilization rates of the notebook rose for the first 7 years after notebook publication but decreased thereafter [27] . Our result is in accordance with these findings and indicates that it is necessary to promote the cooperation of physicians and ophthalmologists, especially for PCC patients.
Previous studies from Japan and elsewhere have reported that microalbuminuria is examined more frequently in patients treated by diabetologists than those treated by GPs [15, [24] [25] [26] . Our results are consistent with these reports [15, 24, 26] , and the proportion examined was B50 % even in the hospitals group, in which most patients were treated by diabetologists. The JDDM (in which participants were treated by diabetologists) reported that 40 % of participants did not undergo measurement of microalbuminuria [28] . To conform to the recommendation, we appeal to the importance of this examination in daily practice.
Our results suggest that it is difficult to achieve target blood pressure both in PCCs and hospitals. The Japan Diabetes Complications Study (JDCS), a prospective study of type 2 diabetic patients treated by diabetologists in Japan, reported that the proportion of patients whose blood pressure was C140/90 mmHg was approximately 40 % and those with blood pressure \130/85 mmHg was \40 % [29] . JDDM reported that the proportion of patients \130/ 80 mmHg was 50 % [23] . According to a report from Europe, the proportion of patients \140/80 mmHg was 29 %, and only 23 % of those with medication for hypertension achieved \140/80 mmHg [30] . Further effort is required toward control of blood pressure in diabetic patients.
Control of LDL-cholesterol was better than that of blood pressure: in 50 % of patients, LDL-cholesterol was B120 mg/dl in the JDCS [29] . Other studies reported that LDL-cholesterol was B130 mg/dl in 66 % [30] and about 50 % of patients [31] . Currently, it seems to be easier than before to reach the target of LDL-cholesterol by the use of strong statins. Our result in 2012 showed that most patients on lipid-lowering drugs had LDL-cholesterol levels \120 mg/dl. This study has several limitations. First, patients with types 1 and 2 diabetes were mixed; most probably, a higher number had type 2 diabetes because the incidence of type 1 diabetes is very low in Japan (1.5/105) [32] . However, most patients with type 1 diabetes might have been treated in hospitals. This might be one of the reasons why patients treated in hospitals used more insulin than those in PCCs. Second, our study potentially has the possibility of selection bias. PCCs and hospitals that have a particular interest in diabetes care may have participated more frequently. The response rate was unclear in this study, although we presume that most medical institutes that provide medical care to diabetic patients participated. Third, HbA1 c measurement was carried out at each clinic or hospital and was not centralized. However, in Japan, the Glycohemoglobin Standardization Committee evaluated the interlaboratory variation of glycohemoglobin (GHb) values and had already reported that the interlaboratory difference in GHb measurement was reduced to a clinically acceptable level [33] . Finally, levels of LDL-cholesterol were calculated by the Friedewald formula; however, data in 2012 were combined with data taken from direct measurement. Directly measured LDL-cholesterol has not been standardized sufficiently in Japan [34] , but it has been included in the national health checkup program since 2008 [35] . LDL-cholesterol measurements obtained by the two methods were highly correlated (r = 0.904, P \ 0.0001) in this study.
In conclusion, this study showed that glycemic control has been improving in Japan. However, examination of diabetic complications and control of blood pressure are still insufficient. Further effort and closer cooperation between PCCs and hospitals is needed to provide appropriate medical care for all diabetic patients.
